USPTO Biotech/Chemical Partnership (BCP) Meetings
In This Section
Biotechnology, Chemical and Pharmaceutical (BCP) Partnership Meeting - September 14, 2015
The United States Patent and Trademark Office
Biotechnology, Chemical and Pharmaceutical (BCP)Partnership Meeting
Monday, September 14, 2015
9:00am to 5:00pm (EDT)
We are pleased to announce the USPTO’s next Biotechnology, Chemical and Pharmaceutical Customer Partnership (BCP) Meeting. This upcoming BCP meeting will be jointly hosted by Technology Centers 1600 (Biotechnology and Organic Chemistry) and 1700 (Chemical and Materials Engineering). This BCP meeting expands our long-standing partnership in these industry sectors to customers across the country. The BCP Meeting will be held on September 14th and will be simultaneously available at locations in the USPTO Headquarters (Alexandria, VA) and the Midwest Regional Office (Detroit, MI). During this BCP, participants will be able to interact with Office personnel in person at both locations, or alternatively, via webcast. Please see below for Registration information on how you can participate.
Date and Location: The Partnership Meeting will be held on September 14th(Monday) from 9:00am – 5:00pm at Alexandria, VA and, at the same time, at Detroit, MI.
Headquarters Location:
USPTO Headquarters
Remsen Conference Center
400 Dulany Street
Alexandria, VA 22314
Midwest Regional Office Location:
Elijah J. McCoy United States Patent and Trademark Office
300 River Place South, Suite 2900
Detroit, MI 48207
The Biotechnology, Chemical and Pharmaceutical Customer Partnership was developed to create a collaborative forum for USPTO customers in this industry sector to share ideas, experiences, and insights with USPTO staff. The BCP is intended to be informal in nature and will include participants from across the industry.
Some of the topics to be discussed by USPTO staff and stakeholders will include:
- Cooperative Patent Classification (CPC) Overview
- Trends in Subject Matter Eligibility for Biotechnology Inventions (A Customer Perspective)
- Practitioner's Perspective on 101 as Applied to Biotech Applications
- Third Party Submission
- AIA 130 Declaration
- PCT National Stage Filing Tips
- Double Patenting
|
9:00 – 9:20am (EDT) |
Welcoming and Opening Remarks |
Christal Sheppard Director, Elijah J. McCoy USPTO (Detroit) |
|
|
|
Jerry Lorengo Director, TC1600, USPTO (Detroit) |
|
|
|
Daniel Sullivan Director, TC1600, USPTO (Alexandria) |
|
|
|
Wanda Walker Director, TC1600, USPTO (Alexandria) |
|
|
|
Gladys Corcoran Director, TC1700, USPTO (Alexandria) |
|
|
|
Yvonne (Bonnie) Eyler Director, TC1700, USPTO (Alexandria) |
|
|
|
Karen Young Director, TC1700, USPTO (Alexandria) |
|
9:20 – 10:00am (EDT) |
Jerry Lorengo Director, TC1600, USPTO (Detroit) |
|
|
10:00 – 11:00am (EDT) |
Practitioner's Perspective on 101 as Applied to Biotech Applications |
Noel E. Day Ph.D. Partner, Honigman Miller Schwartz and Cohn LLP (Detroit) |
|
11:00 – 11:10am (EDT) |
BREAK |
|
|
11:10am – 12:00pm (EDT) |
Trends in Subject Matter Eligibility for Biotechnology Inventions |
Leslie T. Grab Ph.D., Associate Tina W. McKeon, Partner Kilpatrick Townsend & Stockton LLP (Alexandria) |
|
12:00 – 1:00pm (EDT) |
LUNCH |
|
|
1:00 – 2:00pm (EDT) |
Bennett Celsa Quality Assurance Specialist, TC1600, USPTO (Alexandria) |
|
|
2:00 – 3:00pm (EDT) |
Kathleen Fonda Senior Legal Advisor, Office of Patent Legal Administration (OPLA), USPTO (Alexandria) |
|
|
3:00 – 3:10pm (EDT) |
BREAK |
|
|
3:10 – 3:50pm (EDT) |
Corrections/Amendments and Priority/Benefits Claims in International and National Stage |
Susan Wolski PCT Special Programs Examiner, International Patent Legal Administration, USPTO (Alexandria) |
|
3:50 – 4:40pm (EDT) |
James Wilson Supervisory Patent Examiner (SPE), TC1600, USPTO (Alexandria) |
|
|
4:40 – 5:00pm (EDT) |
Closing Remarks |
Directors |